nodes	percent_of_prediction	percent_of_DWPC	metapath
Tenofovir—ABCC10—Methotrexate—systemic scleroderma	0.153	0.221	CbGbCtD
Tenofovir—ABCC2—Mycophenolate mofetil—systemic scleroderma	0.109	0.157	CbGbCtD
Tenofovir—SLC22A6—Captopril—systemic scleroderma	0.102	0.146	CbGbCtD
Tenofovir—ABCC4—Methotrexate—systemic scleroderma	0.0737	0.106	CbGbCtD
Tenofovir—CYP1A2—Pentoxifylline—systemic scleroderma	0.0691	0.0995	CbGbCtD
Tenofovir—CYP1A2—Leflunomide—systemic scleroderma	0.0659	0.0949	CbGbCtD
Tenofovir—SLC22A8—Methotrexate—systemic scleroderma	0.046	0.0663	CbGbCtD
Tenofovir—ABCC2—Methotrexate—systemic scleroderma	0.0438	0.0631	CbGbCtD
Tenofovir—SLC22A6—Methotrexate—systemic scleroderma	0.0321	0.0462	CbGbCtD
Tenofovir—NME1—connective tissue—systemic scleroderma	0.00311	0.094	CbGeAlD
Tenofovir—NME1—skin of body—systemic scleroderma	0.00281	0.0849	CbGeAlD
Tenofovir—AK2—tendon—systemic scleroderma	0.00278	0.0842	CbGeAlD
Tenofovir—NME1—Fluticasone Propionate—Mometasone—systemic scleroderma	0.00247	1	CbGdCrCtD
Tenofovir—AK2—lung—systemic scleroderma	0.00244	0.0739	CbGeAlD
Tenofovir—NME1—digestive system—systemic scleroderma	0.00225	0.0679	CbGeAlD
Tenofovir—AK4—digestive system—systemic scleroderma	0.00216	0.0654	CbGeAlD
Tenofovir—NME2—digestive system—systemic scleroderma	0.00212	0.0639	CbGeAlD
Tenofovir—AK4—tendon—systemic scleroderma	0.00206	0.0623	CbGeAlD
Tenofovir—NME1—lung—systemic scleroderma	0.00188	0.0567	CbGeAlD
Tenofovir—AK4—lung—systemic scleroderma	0.00181	0.0546	CbGeAlD
Tenofovir—NME2—lung—systemic scleroderma	0.00177	0.0534	CbGeAlD
Tenofovir—ABCC10—digestive system—systemic scleroderma	0.00103	0.031	CbGeAlD
Tenofovir—ABCC10—tendon—systemic scleroderma	0.000977	0.0295	CbGeAlD
Tenofovir—ABCC10—lung—systemic scleroderma	0.000857	0.0259	CbGeAlD
Tenofovir—ABCC4—digestive system—systemic scleroderma	0.000852	0.0257	CbGeAlD
Tenofovir—ABCC2—digestive system—systemic scleroderma	0.000824	0.0249	CbGeAlD
Tenofovir—ABCC4—tendon—systemic scleroderma	0.00081	0.0245	CbGeAlD
Tenofovir—ABCC2—tendon—systemic scleroderma	0.000784	0.0237	CbGeAlD
Tenofovir—ABCC4—lung—systemic scleroderma	0.000711	0.0215	CbGeAlD
Tenofovir—CYP1A2—digestive system—systemic scleroderma	0.000579	0.0175	CbGeAlD
Tenofovir—Anxiety—Leflunomide—systemic scleroderma	0.000498	0.00185	CcSEcCtD
Tenofovir—Urethral disorder—Mycophenolate mofetil—systemic scleroderma	0.000498	0.00185	CcSEcCtD
Tenofovir—Flatulence—Lisinopril—systemic scleroderma	0.000497	0.00184	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Leflunomide—systemic scleroderma	0.000497	0.00184	CcSEcCtD
Tenofovir—Skin disorder—Azathioprine—systemic scleroderma	0.000493	0.00183	CcSEcCtD
Tenofovir—Back pain—Lisinopril—systemic scleroderma	0.000488	0.00181	CcSEcCtD
Tenofovir—Vomiting—Pentoxifylline—systemic scleroderma	0.000488	0.00181	CcSEcCtD
Tenofovir—Rash—Pentoxifylline—systemic scleroderma	0.000484	0.00179	CcSEcCtD
Tenofovir—Dermatitis—Pentoxifylline—systemic scleroderma	0.000483	0.00179	CcSEcCtD
Tenofovir—CYP1A2—lung—systemic scleroderma	0.000483	0.0146	CbGeAlD
Tenofovir—Headache—Pentoxifylline—systemic scleroderma	0.000481	0.00178	CcSEcCtD
Tenofovir—Myalgia—Mycophenolic acid—systemic scleroderma	0.000477	0.00177	CcSEcCtD
Tenofovir—Chest pain—Mycophenolic acid—systemic scleroderma	0.000477	0.00177	CcSEcCtD
Tenofovir—Arthralgia—Mycophenolic acid—systemic scleroderma	0.000477	0.00177	CcSEcCtD
Tenofovir—Gastrointestinal pain—Captopril—systemic scleroderma	0.000476	0.00176	CcSEcCtD
Tenofovir—Anxiety—Mycophenolic acid—systemic scleroderma	0.000475	0.00176	CcSEcCtD
Tenofovir—Asthenia—Mometasone—systemic scleroderma	0.000475	0.00176	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Mycophenolic acid—systemic scleroderma	0.000474	0.00176	CcSEcCtD
Tenofovir—Polyuria—Methotrexate—systemic scleroderma	0.000474	0.00176	CcSEcCtD
Tenofovir—Nervous system disorder—Leflunomide—systemic scleroderma	0.00047	0.00174	CcSEcCtD
Tenofovir—Pruritus—Mometasone—systemic scleroderma	0.000468	0.00174	CcSEcCtD
Tenofovir—Skin disorder—Leflunomide—systemic scleroderma	0.000466	0.00173	CcSEcCtD
Tenofovir—Hyperhidrosis—Leflunomide—systemic scleroderma	0.000463	0.00172	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000462	0.00171	CcSEcCtD
Tenofovir—Angioedema—Lisinopril—systemic scleroderma	0.000461	0.00171	CcSEcCtD
Tenofovir—Abdominal pain—Captopril—systemic scleroderma	0.00046	0.0017	CcSEcCtD
Tenofovir—Body temperature increased—Captopril—systemic scleroderma	0.00046	0.0017	CcSEcCtD
Tenofovir—Mediastinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000458	0.0017	CcSEcCtD
Tenofovir—Anorexia—Leflunomide—systemic scleroderma	0.000457	0.00169	CcSEcCtD
Tenofovir—Nausea—Pentoxifylline—systemic scleroderma	0.000456	0.00169	CcSEcCtD
Tenofovir—Diarrhoea—Mometasone—systemic scleroderma	0.000453	0.00168	CcSEcCtD
Tenofovir—Hypokalaemia—Prednisone—systemic scleroderma	0.000453	0.00168	CcSEcCtD
Tenofovir—Renal failure acute—Methotrexate—systemic scleroderma	0.00045	0.00167	CcSEcCtD
Tenofovir—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000448	0.00166	CcSEcCtD
Tenofovir—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.000445	0.00165	CcSEcCtD
Tenofovir—Skin disorder—Mycophenolic acid—systemic scleroderma	0.000444	0.00165	CcSEcCtD
Tenofovir—Malnutrition—Mycophenolate mofetil—systemic scleroderma	0.000442	0.00164	CcSEcCtD
Tenofovir—Hyperhidrosis—Mycophenolic acid—systemic scleroderma	0.000442	0.00164	CcSEcCtD
Tenofovir—Muscular weakness—Prednisone—systemic scleroderma	0.000439	0.00163	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Azathioprine—systemic scleroderma	0.000438	0.00162	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000437	0.00162	CcSEcCtD
Tenofovir—Anorexia—Mycophenolic acid—systemic scleroderma	0.000436	0.00162	CcSEcCtD
Tenofovir—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000436	0.00162	CcSEcCtD
Tenofovir—Insomnia—Leflunomide—systemic scleroderma	0.000433	0.00161	CcSEcCtD
Tenofovir—Chest pain—Lisinopril—systemic scleroderma	0.00043	0.00159	CcSEcCtD
Tenofovir—Arthralgia—Lisinopril—systemic scleroderma	0.00043	0.00159	CcSEcCtD
Tenofovir—Myalgia—Lisinopril—systemic scleroderma	0.00043	0.00159	CcSEcCtD
Tenofovir—Anxiety—Lisinopril—systemic scleroderma	0.000428	0.00159	CcSEcCtD
Tenofovir—Back pain—Mycophenolate mofetil—systemic scleroderma	0.000428	0.00159	CcSEcCtD
Tenofovir—Dyspnoea—Leflunomide—systemic scleroderma	0.000427	0.00158	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—systemic scleroderma	0.000427	0.00158	CcSEcCtD
Tenofovir—Dyspepsia—Leflunomide—systemic scleroderma	0.000422	0.00156	CcSEcCtD
Tenofovir—Pancreatitis—Prednisone—systemic scleroderma	0.000422	0.00156	CcSEcCtD
Tenofovir—Vomiting—Mometasone—systemic scleroderma	0.000421	0.00156	CcSEcCtD
Tenofovir—Rash—Mometasone—systemic scleroderma	0.000417	0.00155	CcSEcCtD
Tenofovir—Asthenia—Captopril—systemic scleroderma	0.000417	0.00155	CcSEcCtD
Tenofovir—Dermatitis—Mometasone—systemic scleroderma	0.000417	0.00155	CcSEcCtD
Tenofovir—Decreased appetite—Leflunomide—systemic scleroderma	0.000417	0.00154	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000417	0.00154	CcSEcCtD
Tenofovir—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000415	0.00154	CcSEcCtD
Tenofovir—Headache—Mometasone—systemic scleroderma	0.000415	0.00154	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Leflunomide—systemic scleroderma	0.000414	0.00153	CcSEcCtD
Tenofovir—Insomnia—Mycophenolic acid—systemic scleroderma	0.000414	0.00153	CcSEcCtD
Tenofovir—Fatigue—Leflunomide—systemic scleroderma	0.000413	0.00153	CcSEcCtD
Tenofovir—Pruritus—Captopril—systemic scleroderma	0.000411	0.00153	CcSEcCtD
Tenofovir—Pain—Leflunomide—systemic scleroderma	0.00041	0.00152	CcSEcCtD
Tenofovir—Dyspnoea—Mycophenolic acid—systemic scleroderma	0.000408	0.00151	CcSEcCtD
Tenofovir—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000404	0.0015	CcSEcCtD
Tenofovir—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000402	0.00149	CcSEcCtD
Tenofovir—Abdominal pain—Azathioprine—systemic scleroderma	0.000401	0.00149	CcSEcCtD
Tenofovir—Body temperature increased—Azathioprine—systemic scleroderma	0.000401	0.00149	CcSEcCtD
Tenofovir—Skin disorder—Lisinopril—systemic scleroderma	0.0004	0.00148	CcSEcCtD
Tenofovir—Hyperhidrosis—Lisinopril—systemic scleroderma	0.000398	0.00148	CcSEcCtD
Tenofovir—Diarrhoea—Captopril—systemic scleroderma	0.000398	0.00148	CcSEcCtD
Tenofovir—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000397	0.00147	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Mycophenolic acid—systemic scleroderma	0.000395	0.00146	CcSEcCtD
Tenofovir—Fatigue—Mycophenolic acid—systemic scleroderma	0.000394	0.00146	CcSEcCtD
Tenofovir—Nausea—Mometasone—systemic scleroderma	0.000393	0.00146	CcSEcCtD
Tenofovir—Anorexia—Lisinopril—systemic scleroderma	0.000393	0.00146	CcSEcCtD
Tenofovir—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000392	0.00145	CcSEcCtD
Tenofovir—Pain—Mycophenolic acid—systemic scleroderma	0.000391	0.00145	CcSEcCtD
Tenofovir—Weight decreased—Prednisone—systemic scleroderma	0.000389	0.00144	CcSEcCtD
Tenofovir—Hyperglycaemia—Prednisone—systemic scleroderma	0.000388	0.00144	CcSEcCtD
Tenofovir—Dizziness—Captopril—systemic scleroderma	0.000385	0.00143	CcSEcCtD
Tenofovir—Depression—Prednisone—systemic scleroderma	0.000382	0.00142	CcSEcCtD
Tenofovir—Body temperature increased—Leflunomide—systemic scleroderma	0.000379	0.0014	CcSEcCtD
Tenofovir—Abdominal pain—Leflunomide—systemic scleroderma	0.000379	0.0014	CcSEcCtD
Tenofovir—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000376	0.0014	CcSEcCtD
Tenofovir—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000376	0.0014	CcSEcCtD
Tenofovir—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000376	0.0014	CcSEcCtD
Tenofovir—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000376	0.00139	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000375	0.00139	CcSEcCtD
Tenofovir—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.000375	0.00139	CcSEcCtD
Tenofovir—Hypersensitivity—Azathioprine—systemic scleroderma	0.000374	0.00139	CcSEcCtD
Tenofovir—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000374	0.00139	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.000374	0.00139	CcSEcCtD
Tenofovir—Insomnia—Lisinopril—systemic scleroderma	0.000372	0.00138	CcSEcCtD
Tenofovir—Vomiting—Captopril—systemic scleroderma	0.00037	0.00137	CcSEcCtD
Tenofovir—Dyspnoea—Lisinopril—systemic scleroderma	0.000367	0.00136	CcSEcCtD
Tenofovir—Rash—Captopril—systemic scleroderma	0.000367	0.00136	CcSEcCtD
Tenofovir—Dermatitis—Captopril—systemic scleroderma	0.000366	0.00136	CcSEcCtD
Tenofovir—Headache—Captopril—systemic scleroderma	0.000364	0.00135	CcSEcCtD
Tenofovir—Dyspepsia—Lisinopril—systemic scleroderma	0.000363	0.00134	CcSEcCtD
Tenofovir—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000361	0.00134	CcSEcCtD
Tenofovir—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000361	0.00134	CcSEcCtD
Tenofovir—Decreased appetite—Lisinopril—systemic scleroderma	0.000358	0.00133	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000356	0.00132	CcSEcCtD
Tenofovir—Fatigue—Lisinopril—systemic scleroderma	0.000355	0.00132	CcSEcCtD
Tenofovir—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.000354	0.00131	CcSEcCtD
Tenofovir—Hypersensitivity—Leflunomide—systemic scleroderma	0.000353	0.00131	CcSEcCtD
Tenofovir—Pancreatitis—Methotrexate—systemic scleroderma	0.000352	0.00131	CcSEcCtD
Tenofovir—Pain—Lisinopril—systemic scleroderma	0.000352	0.00131	CcSEcCtD
Tenofovir—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.00035	0.0013	CcSEcCtD
Tenofovir—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000349	0.00129	CcSEcCtD
Tenofovir—Diarrhoea—Azathioprine—systemic scleroderma	0.000347	0.00129	CcSEcCtD
Tenofovir—Nausea—Captopril—systemic scleroderma	0.000345	0.00128	CcSEcCtD
Tenofovir—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000344	0.00128	CcSEcCtD
Tenofovir—Asthenia—Leflunomide—systemic scleroderma	0.000344	0.00128	CcSEcCtD
Tenofovir—Pruritus—Leflunomide—systemic scleroderma	0.000339	0.00126	CcSEcCtD
Tenofovir—Connective tissue disorder—Prednisone—systemic scleroderma	0.000338	0.00125	CcSEcCtD
Tenofovir—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000337	0.00125	CcSEcCtD
Tenofovir—Dizziness—Azathioprine—systemic scleroderma	0.000336	0.00124	CcSEcCtD
Tenofovir—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000334	0.00124	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000329	0.00122	CcSEcCtD
Tenofovir—Asthenia—Mycophenolic acid—systemic scleroderma	0.000328	0.00122	CcSEcCtD
Tenofovir—Diarrhoea—Leflunomide—systemic scleroderma	0.000328	0.00122	CcSEcCtD
Tenofovir—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000326	0.00121	CcSEcCtD
Tenofovir—Abdominal pain—Lisinopril—systemic scleroderma	0.000326	0.00121	CcSEcCtD
Tenofovir—Body temperature increased—Lisinopril—systemic scleroderma	0.000326	0.00121	CcSEcCtD
Tenofovir—Pruritus—Mycophenolic acid—systemic scleroderma	0.000323	0.0012	CcSEcCtD
Tenofovir—Vomiting—Azathioprine—systemic scleroderma	0.000323	0.0012	CcSEcCtD
Tenofovir—Pneumonia—Methotrexate—systemic scleroderma	0.000322	0.0012	CcSEcCtD
Tenofovir—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000322	0.00119	CcSEcCtD
Tenofovir—Infestation—Methotrexate—systemic scleroderma	0.000321	0.00119	CcSEcCtD
Tenofovir—Infestation NOS—Methotrexate—systemic scleroderma	0.000321	0.00119	CcSEcCtD
Tenofovir—Rash—Azathioprine—systemic scleroderma	0.00032	0.00119	CcSEcCtD
Tenofovir—Dermatitis—Azathioprine—systemic scleroderma	0.00032	0.00119	CcSEcCtD
Tenofovir—Depression—Methotrexate—systemic scleroderma	0.00032	0.00119	CcSEcCtD
Tenofovir—Headache—Azathioprine—systemic scleroderma	0.000318	0.00118	CcSEcCtD
Tenofovir—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000318	0.00118	CcSEcCtD
Tenofovir—Dizziness—Leflunomide—systemic scleroderma	0.000317	0.00118	CcSEcCtD
Tenofovir—Renal failure—Methotrexate—systemic scleroderma	0.000315	0.00117	CcSEcCtD
Tenofovir—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000314	0.00116	CcSEcCtD
Tenofovir—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000313	0.00116	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000312	0.00116	CcSEcCtD
Tenofovir—Immune system disorder—Prednisone—systemic scleroderma	0.000311	0.00115	CcSEcCtD
Tenofovir—Pain—Mycophenolate mofetil—systemic scleroderma	0.000309	0.00114	CcSEcCtD
Tenofovir—Sweating—Methotrexate—systemic scleroderma	0.000307	0.00114	CcSEcCtD
Tenofovir—Haematuria—Methotrexate—systemic scleroderma	0.000306	0.00113	CcSEcCtD
Tenofovir—Vomiting—Leflunomide—systemic scleroderma	0.000305	0.00113	CcSEcCtD
Tenofovir—Hypersensitivity—Lisinopril—systemic scleroderma	0.000303	0.00113	CcSEcCtD
Tenofovir—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000303	0.00112	CcSEcCtD
Tenofovir—Dizziness—Mycophenolic acid—systemic scleroderma	0.000302	0.00112	CcSEcCtD
Tenofovir—Rash—Leflunomide—systemic scleroderma	0.000302	0.00112	CcSEcCtD
Tenofovir—Dermatitis—Leflunomide—systemic scleroderma	0.000302	0.00112	CcSEcCtD
Tenofovir—Mental disorder—Prednisone—systemic scleroderma	0.000302	0.00112	CcSEcCtD
Tenofovir—Nausea—Azathioprine—systemic scleroderma	0.000301	0.00112	CcSEcCtD
Tenofovir—Headache—Leflunomide—systemic scleroderma	0.0003	0.00111	CcSEcCtD
Tenofovir—Malnutrition—Prednisone—systemic scleroderma	0.0003	0.00111	CcSEcCtD
Tenofovir—Asthenia—Lisinopril—systemic scleroderma	0.000295	0.0011	CcSEcCtD
Tenofovir—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000295	0.00109	CcSEcCtD
Tenofovir—Pruritus—Lisinopril—systemic scleroderma	0.000291	0.00108	CcSEcCtD
Tenofovir—Vomiting—Mycophenolic acid—systemic scleroderma	0.000291	0.00108	CcSEcCtD
Tenofovir—Rash—Mycophenolic acid—systemic scleroderma	0.000288	0.00107	CcSEcCtD
Tenofovir—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000288	0.00107	CcSEcCtD
Tenofovir—Hepatitis—Methotrexate—systemic scleroderma	0.000288	0.00107	CcSEcCtD
Tenofovir—Headache—Mycophenolic acid—systemic scleroderma	0.000286	0.00106	CcSEcCtD
Tenofovir—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000285	0.00106	CcSEcCtD
Tenofovir—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000285	0.00106	CcSEcCtD
Tenofovir—Nausea—Leflunomide—systemic scleroderma	0.000285	0.00106	CcSEcCtD
Tenofovir—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000284	0.00105	CcSEcCtD
Tenofovir—Urethral disorder—Methotrexate—systemic scleroderma	0.000282	0.00105	CcSEcCtD
Tenofovir—Diarrhoea—Lisinopril—systemic scleroderma	0.000282	0.00104	CcSEcCtD
Tenofovir—Angioedema—Prednisone—systemic scleroderma	0.000274	0.00102	CcSEcCtD
Tenofovir—Dizziness—Lisinopril—systemic scleroderma	0.000272	0.00101	CcSEcCtD
Tenofovir—Nausea—Mycophenolic acid—systemic scleroderma	0.000272	0.00101	CcSEcCtD
Tenofovir—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000266	0.000986	CcSEcCtD
Tenofovir—Vomiting—Lisinopril—systemic scleroderma	0.000262	0.000971	CcSEcCtD
Tenofovir—Immune system disorder—Methotrexate—systemic scleroderma	0.00026	0.000964	CcSEcCtD
Tenofovir—Rash—Lisinopril—systemic scleroderma	0.00026	0.000963	CcSEcCtD
Tenofovir—Dermatitis—Lisinopril—systemic scleroderma	0.000259	0.000962	CcSEcCtD
Tenofovir—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000259	0.000962	CcSEcCtD
Tenofovir—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000259	0.00096	CcSEcCtD
Tenofovir—Headache—Lisinopril—systemic scleroderma	0.000258	0.000957	CcSEcCtD
Tenofovir—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000255	0.000947	CcSEcCtD
Tenofovir—Arthralgia—Prednisone—systemic scleroderma	0.000255	0.000946	CcSEcCtD
Tenofovir—Myalgia—Prednisone—systemic scleroderma	0.000255	0.000946	CcSEcCtD
Tenofovir—Anxiety—Prednisone—systemic scleroderma	0.000254	0.000943	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000253	0.00094	CcSEcCtD
Tenofovir—Mental disorder—Methotrexate—systemic scleroderma	0.000252	0.000935	CcSEcCtD
Tenofovir—Malnutrition—Methotrexate—systemic scleroderma	0.00025	0.000929	CcSEcCtD
Tenofovir—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000247	0.000915	CcSEcCtD
Tenofovir—Nausea—Lisinopril—systemic scleroderma	0.000245	0.000907	CcSEcCtD
Tenofovir—Back pain—Methotrexate—systemic scleroderma	0.000242	0.000898	CcSEcCtD
Tenofovir—Nervous system disorder—Prednisone—systemic scleroderma	0.00024	0.000889	CcSEcCtD
Tenofovir—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000239	0.000885	CcSEcCtD
Tenofovir—Skin disorder—Prednisone—systemic scleroderma	0.000238	0.000881	CcSEcCtD
Tenofovir—Hyperhidrosis—Prednisone—systemic scleroderma	0.000236	0.000877	CcSEcCtD
Tenofovir—Anorexia—Prednisone—systemic scleroderma	0.000233	0.000865	CcSEcCtD
Tenofovir—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000229	0.000851	CcSEcCtD
Tenofovir—Rash—Mycophenolate mofetil—systemic scleroderma	0.000228	0.000844	CcSEcCtD
Tenofovir—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000227	0.000843	CcSEcCtD
Tenofovir—Headache—Mycophenolate mofetil—systemic scleroderma	0.000226	0.000838	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000223	0.000826	CcSEcCtD
Tenofovir—Insomnia—Prednisone—systemic scleroderma	0.000221	0.00082	CcSEcCtD
Tenofovir—Dyspepsia—Prednisone—systemic scleroderma	0.000215	0.000798	CcSEcCtD
Tenofovir—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000214	0.000795	CcSEcCtD
Tenofovir—Myalgia—Methotrexate—systemic scleroderma	0.000213	0.000791	CcSEcCtD
Tenofovir—Arthralgia—Methotrexate—systemic scleroderma	0.000213	0.000791	CcSEcCtD
Tenofovir—Chest pain—Methotrexate—systemic scleroderma	0.000213	0.000791	CcSEcCtD
Tenofovir—Decreased appetite—Prednisone—systemic scleroderma	0.000213	0.000788	CcSEcCtD
Tenofovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	0.000212	0.000785	CcSEcCtD
Tenofovir—Fatigue—Prednisone—systemic scleroderma	0.000211	0.000782	CcSEcCtD
Tenofovir—Nervous system disorder—Methotrexate—systemic scleroderma	0.0002	0.000743	CcSEcCtD
Tenofovir—Gastrointestinal pain—Prednisone—systemic scleroderma	0.0002	0.000742	CcSEcCtD
Tenofovir—Skin disorder—Methotrexate—systemic scleroderma	0.000199	0.000736	CcSEcCtD
Tenofovir—Hyperhidrosis—Methotrexate—systemic scleroderma	0.000198	0.000733	CcSEcCtD
Tenofovir—Anorexia—Methotrexate—systemic scleroderma	0.000195	0.000723	CcSEcCtD
Tenofovir—Abdominal pain—Prednisone—systemic scleroderma	0.000193	0.000717	CcSEcCtD
Tenofovir—Body temperature increased—Prednisone—systemic scleroderma	0.000193	0.000717	CcSEcCtD
Tenofovir—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000186	0.000691	CcSEcCtD
Tenofovir—Insomnia—Methotrexate—systemic scleroderma	0.000185	0.000686	CcSEcCtD
Tenofovir—Dyspnoea—Methotrexate—systemic scleroderma	0.000182	0.000676	CcSEcCtD
Tenofovir—Hypersensitivity—Prednisone—systemic scleroderma	0.00018	0.000668	CcSEcCtD
Tenofovir—Dyspepsia—Methotrexate—systemic scleroderma	0.00018	0.000667	CcSEcCtD
Tenofovir—Decreased appetite—Methotrexate—systemic scleroderma	0.000178	0.000659	CcSEcCtD
Tenofovir—Gastrointestinal disorder—Methotrexate—systemic scleroderma	0.000176	0.000654	CcSEcCtD
Tenofovir—Fatigue—Methotrexate—systemic scleroderma	0.000176	0.000654	CcSEcCtD
Tenofovir—Asthenia—Prednisone—systemic scleroderma	0.000175	0.000651	CcSEcCtD
Tenofovir—Pain—Methotrexate—systemic scleroderma	0.000175	0.000648	CcSEcCtD
Tenofovir—Pruritus—Prednisone—systemic scleroderma	0.000173	0.000642	CcSEcCtD
Tenofovir—Diarrhoea—Prednisone—systemic scleroderma	0.000167	0.000621	CcSEcCtD
Tenofovir—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000167	0.00062	CcSEcCtD
Tenofovir—Dizziness—Prednisone—systemic scleroderma	0.000162	0.0006	CcSEcCtD
Tenofovir—Abdominal pain—Methotrexate—systemic scleroderma	0.000162	0.000599	CcSEcCtD
Tenofovir—Body temperature increased—Methotrexate—systemic scleroderma	0.000162	0.000599	CcSEcCtD
Tenofovir—Vomiting—Prednisone—systemic scleroderma	0.000156	0.000577	CcSEcCtD
Tenofovir—Rash—Prednisone—systemic scleroderma	0.000154	0.000572	CcSEcCtD
Tenofovir—Dermatitis—Prednisone—systemic scleroderma	0.000154	0.000571	CcSEcCtD
Tenofovir—Headache—Prednisone—systemic scleroderma	0.000153	0.000568	CcSEcCtD
Tenofovir—Hypersensitivity—Methotrexate—systemic scleroderma	0.000151	0.000558	CcSEcCtD
Tenofovir—Asthenia—Methotrexate—systemic scleroderma	0.000147	0.000544	CcSEcCtD
Tenofovir—Nausea—Prednisone—systemic scleroderma	0.000145	0.000539	CcSEcCtD
Tenofovir—Pruritus—Methotrexate—systemic scleroderma	0.000145	0.000536	CcSEcCtD
Tenofovir—Diarrhoea—Methotrexate—systemic scleroderma	0.00014	0.000519	CcSEcCtD
Tenofovir—Dizziness—Methotrexate—systemic scleroderma	0.000135	0.000501	CcSEcCtD
Tenofovir—Vomiting—Methotrexate—systemic scleroderma	0.00013	0.000482	CcSEcCtD
Tenofovir—Rash—Methotrexate—systemic scleroderma	0.000129	0.000478	CcSEcCtD
Tenofovir—Dermatitis—Methotrexate—systemic scleroderma	0.000129	0.000477	CcSEcCtD
Tenofovir—Headache—Methotrexate—systemic scleroderma	0.000128	0.000475	CcSEcCtD
Tenofovir—Nausea—Methotrexate—systemic scleroderma	0.000121	0.00045	CcSEcCtD
